*The United States鈥� Food and Drug Administration says the equipment that performs the test is about the size of a small suitcase, and it could be deployed in hospitals, medical offices, and other test sites

Alexander Davis | 绿帽献妻

The United States鈥� Food and Drug Administration (FDA) has granted Emergency Use Authorisation (EUA) for a breathalyzer test that indicates the presence of the Coronavirus.

绿帽献妻 gathered the test, produced by InspectIR Systems, collects a breath sample and analyses it for chemical compounds associated with the virus that causes COVID-19.

The FDA was likely impressed with the results of a clinical trial. In a study of 2,409 people, the test correctly returned correct positive readings 91.2 percent of the time and correctly delivered negative results 99.3 percent of the time.

The equipment that performs the test is about the size of a small suitcase. The FDA said it could be deployed in hospitals, medical offices, and other test sites.

US updates COVID-19 travel advisories

The US State Department has announced that it will change how it advises US citizens about foreign travel, with those recommendations being based on the Centers for Disease Control and Prevention鈥檚 (CDC) updated guidelines.

The CDC says the change will reduce the number of countries the government recommends avoiding.

Under the new system, the US will limit 鈥淟evel 4鈥� classification to countries where the virus is rapidly spreading.

Level 4 destinations currently, include most of Europe, Brazil, Turkey, Russia, South Korea, Singapore, Hong Kong, Israel, and Australia.

鈥淭his update will leave approximately 10 percent of all Travel Advisories at Level 4: Do Not Travel,鈥� the State Department said in a Travel Advisory Update.

鈥淭his 10 percent includes Level 4 Travel Advisories for all risk indicators, not just COVID-19.

鈥淲e believe the updated framework will help US citizens make better informed decisions about the safety of international travel.鈥�